Pharmaceutical Product Development, LLC’s $900 Million High Yield Debt Offering and Consent Solicitation

Simpson Thacher represented Eagle Holding Company II, LLC (the “Issuer”), an indirect parent of Pharmaceutical Product Development, LLC (“PPD”), in connection with a Rule 144/Regulation S…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now